Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Lung Neoplasms and SSR1[original query] |
---|
The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer. International journal of cancer. Journal international du cancer 2007 Mar 120 (6): 1239-47. Ichihara S, Toyooka S, Fujiwara Y, Hotta K, Shigematsu H, Tokumo M, Soh J, Asano H, Ichimura K, Aoe K, Aoe M, Kiura K, Shimizu K, Date H, Shimizu N |
Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Nov 29 (31): 4113-20. Brugger Wolfram, Triller Nadja, Blasinska-Morawiec Maria, Curescu Stefan, Sakalauskas Raimundas, Manikhas Georgy Moiseevich, Mazieres Julien, Whittom Renaud, Ward Carol, Mayne Karen, Trunzer Kerstin, Cappuzzo Federi |
EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI. Yonsei medical journal 2012 Nov 53 (6): 6. Jung M, Cho BC, Lee CH, Park HS, Kang YA, Kim SK, Chang J, Kim DJ, Rha SY, Kim JH, Lee JH |
Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma. OncoTargets and therapy 2016 9 5257-70. Guo Haisheng, Xing Yunhui, Mu Ailan, Li Xia, Li Tingshan, Bian Xia, Yang Chunmei, Zhang Xiaolei, Liu Yuefen, Wang Xung |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: